ArticleBMC public health2025
A cross-sectional survey of COVID-19 testing status among vaccine recipients in Gombe State, North-Eastern Nigeria.
Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The COVID-19 testing status and vaccine acceptance are two key components of any COVID-19 control program as they are important in evaluating the prevalence of the disease as well as curbing the spread of the SARS-CoV-2, the causative agent of COVID-19. Hence, the aim of this study was to conduct a non-probability cross-sectional survey of COVID-19 vaccine recipients in Gombe State to determine their testing status and socio-demographic profiles. A total of 872 vaccine recipients were included in this study. The descriptive analysis revealed that the median age group was 30-39 years. More than half (57.7%, n = 503) of the study participants earned 50,000 Naira or less and approximately 51% of the vaccine recipients (n = 444) had tertiary education. Approximately one-third (35.1%, n = 306/872) of the study participants have been previously screened for SARS-CoV-2 and the COVID-19 positivity rate among them was 6.9% (n = 21/306). Some 108 (18.2%) persons reported Adverse Event Following Immunization (AEFI). The multivariable logistic regression analysis revealed that the age [30-39 years, (OR: 1.76; 95% CI: 1.13, 2.74; p = 0.041)], monthly income [150,000 naira and above (OR: 10.43; 95% CI: 2.22, 21.88; p < 0.001)], and background [health-related, (OR: 6.30; 95% CI: 4.35, 9.13; p = 0.01)] of the vaccine recipients was significantly associated with the COVID-19 testing status. The COVID-19 testing status of vaccine recipients is low. Hence, mass COVID-19 screening strategies should be implemented together with improved vaccine advocacy to focus on vaccine safety and efficacy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.